INFI
Infinity Pharmaceuticals, Inc.
INFI
INFI
Delisted
INFI was delisted on the 13th of September, 2023.
98 hedge funds and large institutions have $570M invested in Infinity Pharmaceuticals, Inc. in 2014 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 37 increasing their positions, 29 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
51% less call options, than puts
Call options by funds: $4.43M | Put options by funds: $9.12M
Holders
98
Holding in Top 10
1
Calls
$4.43M
Puts
$9.12M
Top Buyers
| 1 | +$15M | |
| 2 | +$12.5M | |
| 3 | +$8.32M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$7.42M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.79M |
Top Sellers
| 1 | -$9.96M | |
| 2 | -$5.97M | |
| 3 | -$4.83M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$4.59M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$4.38M |